Global Non-Invasive Prenatal Testing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Non-Invasive Prenatal Testing Market Research Report 2024
Non-Invasive Prenatal Testing is a method of determining the risk that the fetus will be born with certain genetic abnormalities. This testing analyzes small fragments of DNA that are circulating in a pregnant woman's blood
According to MRAResearch’s new survey, global Non-Invasive Prenatal Testing market is projected to reach US$ 10060 million in 2033, increasing from US$ 4884.4 million in 2022, with the CAGR of 10.7% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non-Invasive Prenatal Testing market research.
Key companies engaged in the Non-Invasive Prenatal Testing industry include Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina and Berry Genomics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Non-Invasive Prenatal Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Non-Invasive Prenatal Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Non-Invasive Prenatal Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Sequenom
Roche
Natera
LabCorp
BGI Genomics
Quest Diagnostics
Illumina
Berry Genomics
Segment by Type
High & Average Risk
Low Risk
0-12 Weeks
13-24 Weeks
25-36 Weeks
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Non-Invasive Prenatal Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Non-Invasive Prenatal Testing market is projected to reach US$ 10060 million in 2033, increasing from US$ 4884.4 million in 2022, with the CAGR of 10.7% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non-Invasive Prenatal Testing market research.
Key companies engaged in the Non-Invasive Prenatal Testing industry include Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina and Berry Genomics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Non-Invasive Prenatal Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Non-Invasive Prenatal Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Non-Invasive Prenatal Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sequenom
Roche
Natera
LabCorp
BGI Genomics
Quest Diagnostics
Illumina
Berry Genomics
Segment by Type
High & Average Risk
Low Risk
Segment by Application
0-12 Weeks
13-24 Weeks
25-36 Weeks
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Non-Invasive Prenatal Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source